These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management and preparedness for infusion and hypersensitivity reactions. Lenz HJ Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Lee C; Gianos M; Klaustermeyer WB Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063 [TBL] [Abstract][Full Text] [Related]
7. Nonallergic drug hypersensitivity reactions. Farnam K; Chang C; Teuber S; Gershwin ME Int Arch Allergy Immunol; 2012; 159(4):327-45. PubMed ID: 22832422 [TBL] [Abstract][Full Text] [Related]
8. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insect stings. Sicherer SH; Leung DY J Allergy Clin Immunol; 2004 Jul; 114(1):118-24. PubMed ID: 15241353 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to oxaliplatin: what nurses need to know. Bonosky K; Miller R Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843 [TBL] [Abstract][Full Text] [Related]
11. IgE-mediated anaphylaxis and allergic reactions to idursulfase in patients with Hunter syndrome. Kim J; Park MR; Kim DS; Lee JO; Maeng SH; Cho SY; Han Y; Ahn K; Jin DK Allergy; 2013 Jun; 68(6):796-802. PubMed ID: 23621439 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and biotherapy-induced hypersensitivity reactions. Van Gerpen R J Infus Nurs; 2009; 32(3):157-65. PubMed ID: 19444023 [TBL] [Abstract][Full Text] [Related]
13. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Hong DI; Bankova L; Cahill KN; Kyin T; Castells MC Expert Rev Clin Immunol; 2012 Jan; 8(1):43-52; quiz 53-4. PubMed ID: 22149339 [TBL] [Abstract][Full Text] [Related]
14. The impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: a European perspective. Chadda S; Larkin M; Jones C; Sykes D; Barber B; Zhao Z; Gao S; Bengttson NO J Oncol Pharm Pract; 2013 Mar; 19(1):38-47. PubMed ID: 22735081 [TBL] [Abstract][Full Text] [Related]
15. Anaphylaxis: implications of monoclonal antibody use in oncology. Gleich GJ; Leiferman KM Oncology (Williston Park); 2009 Feb; 23(2 Suppl 1):7-13. PubMed ID: 19385161 [TBL] [Abstract][Full Text] [Related]
16. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009. Sicherer SH; Leung DY J Allergy Clin Immunol; 2010 Jan; 125(1):85-97. PubMed ID: 20109740 [TBL] [Abstract][Full Text] [Related]
17. Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy. Wilkes G Clin J Oncol Nurs; 2008 Jun; 12(3):530-2. PubMed ID: 18515254 [No Abstract] [Full Text] [Related]
18. Acute infusion reactions to chemotherapeutic drugs: a single institute experience. Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O J BUON; 2013; 18(1):261-7. PubMed ID: 23613414 [TBL] [Abstract][Full Text] [Related]
19. [Infusion reaction and anaphylaxis]. Yoshida K; Shiono M; Ishioka C Gan To Kagaku Ryoho; 2011 Nov; 38(11):1753-7. PubMed ID: 22083179 [TBL] [Abstract][Full Text] [Related]